(ESLT) Elbit Systems - Overview
Sector: IndustrialsIndustry: Aerospace & Defense | Exchange NASDAQ (USA) | Currency USD | Market Cap: 41.357m | Total Return 114.1% in 12m
Avg Trading Vol: 198M USD
Peers RS (IBD): 99.0
EPS Trend: 90.1%
Qual. Beats: 8
Rev. Trend: 94.5%
Qual. Beats: 1
P/E ratio: 76.367
Elbit Systems Ltd. (ESLT) is an Israeli defense company. It develops and supplies airborne, land, and naval systems for defense, homeland security, and commercial aviation. The defense industry is characterized by long sales cycles and government contracts.
The company operates through five segments: Aerospace; C4I and Cyber; ISTAR and EW; Land; and Elbit Systems of America. Its offerings include unmanned aerial solutions, precision-guided munitions, C4ISR systems, cyber intelligence, and electronic warfare systems. Defense contractors often serve as prime contractors or subcontractors to governments globally.
ESLTs product lines also include electro-optic laser solutions, naval systems, and land-based systems for military vehicles and artillery. The company targets military, homeland security, and commercial aviation customers in multiple regions. To understand ESLTs market position and financial health, further research on platforms like ValueRay is recommended.
- Global defense spending increases drive demand for advanced military systems
- Geopolitical instability boosts sales of C4ISR and EW solutions
- US military budget allocations impact Elbit Systems of America revenue
- Commercial aviation downturn reduces aerospace segment profitability
- Regulatory hurdles and export controls restrict international sales
| Net Income: 543.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.54 > 1.0 |
| NWC/Revenue: 21.80% < 20% (prev 15.32%; Δ 6.48% < -1%) |
| CFO/TA 0.06 > 3% & CFO 794.9m > Net Income 543.8m |
| Net Debt (329.7m) to EBITDA (861.4m): 0.38 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.8m) vs 12m ago 6.28% < -2% |
| Gross Margin: 24.38% > 18% (prev 0.24%; Δ 2.41k% > 0.5%) |
| Asset Turnover: 68.27% > 50% (prev 62.10%; Δ 6.16% > 0%) |
| Interest Coverage Ratio: 4.92 > 6 (EBITDA TTM 861.4m / Interest Expense TTM 139.8m) |
| A: 0.14 (Total Current Assets 7.74b - Total Current Liabilities 5.98b) / Total Assets 12.66b |
| B: 0.25 (Retained Earnings 3.15b / Total Assets 12.66b) |
| C: 0.06 (EBIT TTM 687.2m / Avg Total Assets 11.82b) |
| D: 0.36 (Book Value of Equity 3.07b / Total Liabilities 8.53b) |
| Altman-Z'' Score: 2.49 = A |
| DSRI: 0.95 (Receivables 3.57b/3.18b, Revenue 8.07b/6.81b) |
| GMI: 0.99 (GM 24.38% / 24.05%) |
| AQI: 0.93 (AQ_t 0.24 / AQ_t-1 0.26) |
| SGI: 1.18 (Revenue 8.07b / 6.81b) |
| TATA: -0.02 (NI 543.8m - CFO 794.9m) / TA 12.66b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
Over the past week, the price has changed by -9.55%, over one month by +6.21%, over three months by +41.07% and over the past year by +114.11%.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 754.7 | -7.6% |
| Analysts Target Price | 754.7 | -7.6% |
P/E Forward = 9.6618
P/S = 5.2096
P/B = 10.3766
P/EG = 8.7866
Revenue TTM = 8.07b USD
EBIT TTM = 687.2m USD
EBITDA TTM = 861.4m USD
Long Term Debt = 255.6m USD (from longTermDebt, last quarter)
Short Term Debt = 232.5m USD (from shortTermDebt, last quarter)
Debt = 965.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 329.7m USD (from netDebt column, last quarter)
Enterprise Value = 41.51b USD (41.36b + Debt 965.0m - CCE 815.9m)
Interest Coverage Ratio = 4.92 (Ebit TTM 687.2m / Interest Expense TTM 139.8m)
EV/FCF = 73.59x (Enterprise Value 41.51b / FCF TTM 564.0m)
FCF Yield = 1.36% (FCF TTM 564.0m / Enterprise Value 41.51b)
FCF Margin = 6.99% (FCF TTM 564.0m / Revenue TTM 8.07b)
Net Margin = 6.74% (Net Income TTM 543.8m / Revenue TTM 8.07b)
Gross Margin = 24.38% ((Revenue TTM 8.07b - Cost of Revenue TTM 6.10b) / Revenue TTM)
Gross Margin QoQ = 24.66% (prev 24.89%)
Tobins Q-Ratio = 3.28 (Enterprise Value 41.51b / Total Assets 12.66b)
Interest Expense / Debt = 3.60% (Interest Expense 34.7m / Debt 965.0m)
Taxrate = 11.08% (21.4m / 193.5m)
NOPAT = 611.1m (EBIT 687.2m * (1 - 11.08%))
Current Ratio = 1.29 (Total Current Assets 7.74b / Total Current Liabilities 5.98b)
Debt / Equity = 0.23 (Debt 965.0m / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 0.38 (Net Debt 329.7m / EBITDA 861.4m)
Debt / FCF = 0.58 (Net Debt 329.7m / FCF TTM 564.0m)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.60% (Net Income 543.8m / Total Assets 12.66b)
RoE = 14.14% (Net Income TTM 543.8m / Total Stockholder Equity 3.84b)
RoCE = 16.76% (EBIT 687.2m / Capital Employed (Equity 3.84b + L.T.Debt 255.6m))
RoIC = 13.70% (NOPAT 611.1m / Invested Capital 4.46b)
WACC = 6.11% (E(41.36b)/V(42.32b) * Re(6.18%) + D(965.0m)/V(42.32b) * Rd(3.60%) * (1-Tc(0.11)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 3.45%
[DCF] Terminal Value 80.21% ; FCFF base≈466.2m ; Y1≈306.1m ; Y5≈140.0m
[DCF] Fair Price = 85.17 (EV 4.29b - Net Debt 329.7m = Equity 3.96b / Shares 46.5m; r=6.11% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 90.09 | EPS CAGR: 33.05% | SUE: 4.0 | # QB: 8
Revenue Correlation: 94.53 | Revenue CAGR: 13.75% | SUE: 0.98 | # QB: 1
EPS next Quarter (2026-06-30): EPS=3.53 | Chg7d=+0.202 | Chg30d=+0.202 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=14.46 | Chg7d=+0.600 | Chg30d=+0.600 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+12.2%
EPS next Year (2027-12-31): EPS=16.82 | Chg7d=+1.067 | Chg30d=+1.067 | Revisions Net=+1 | Growth EPS=+16.3% | Growth Revenue=+9.2%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.6% (Discount Rate 7.9% - Earnings Yield 1.3%)
[Growth] Growth Spread = +3.1% (Analyst 9.8% - Implied 6.6%)